NEW YORK, Dec. 12 (GenomeWeb News) - Applera has agreed to pay Genetic Technologies an undisclosed amount to settle their ongoing patent-infringement suit surrounding the firm's junk DNA gene-testing technologies, according to Genetic Technologies.
While details of the 18-hour mediation session that resulted in the settlement remain confidential, the companies executed several binding agreements, including a final settlement agreement, a license agreement, and a supply agreement, according to an announcement made to Gene Technologies shareholders today. All claims and counterclaims will be dismissed, the firm said.
The technologies on which the case was built represents the only US patent on the use of non-coding DNA markers for gene testing.
Genetic Technologies originally sued Applera and two other US companies in March 2003 for not purchasing licenses and paying royalties. The other companies settled separately in November 2004. Applera agreed to pursue further negotiations on Oct. 13 and both sides agreed to a settlement on Dec. 9.